Risk
27. February 2024
5 minutes

Reduce cluster risks in the Swiss equity market

The "magnificent seven", i.e. the US technology giants such as Apple, Microsoft and co, have repeatedly made the headlines in recent years. Due to their sheer size, they have dominated the performance of many cap-weighted indices and, as in 2023, have generated substantial gains. Something similar can be observed on the Swiss stock market and serves as an illustrative example of how a top-heavy index can sometimes tip over.

The SPI - a top-heavy index

In contrast to the US stock market, it is not stocks from the dynamic technology sector that are dominating the market in Switzerland, but three heavyweights from the more defensive food and healthcare sector. Everyone knows them: Nestlé, Novartis and Roche. Together they represent just under 45% of the Swiss Performance Index (SPI) as at 31.12.2023. By design, companies with a large market capitalization (large caps) have a relatively large weighting in a capital-weighted index compared to small and mid caps. In the case of the SPI (219 stocks in total), the large caps segment has a market share of 81%, but comprises just 20 companies - with the "Big 3" accounting for over half of this share.

81% of the weighting concentrated on 20 large caps with a total of 219 companies in the index.

What was that again about diversification?

It is always debatable whether an index methodology makes sense or not. However, it is surprising that for many investors the SPI is the benchmark and usually also the passive investment solution for the Swiss equity universe. When putting together a portfolio, diversification should actually be the top priority - in other words, the principle of "not putting all your eggs in the same basket". However, anyone investing passively in the SPI is doing pretty much exactly that and is not only running a very large cluster risk in the "Big 3", but also has concentration risks in the healthcare sector and in the largest companies in general.

While the defensive nature of the three index heavyweights ensured stability in the SPI at times, the major individual stock risk manifested itself over the longer term and again last year. Nestlé and Roche disappointed due to company-specific circumstances in what was otherwise a positive 2023, dragging the index down significantly. All the better advised were those who had solidly diversified their money.

Performance comparison: Index heavyweights vs. SPI and SMI Mid Cap (SMIM) Index

Recommendation No. 1 - Turn away from the index!

If you want to better diversify your portfolio, the only option is to consistently deviate from the capital-weighted SPI. Of course, this can be done in different directions. As we at OLZ always place investment risk at the heart of our investment decisions, we believe that a risk-optimized equity portfolio is the right way to achieve long-term success.

We have been implementing this in our OLZ Equity Switzerland Optimized ESG fund for over 12 years. The OLZ minimum risk approach results in a portfolio that systematically reduces volatility and concentration risks and thus ensures a more robust portfolio performance, particularly in times of stress, without reducing long-term returns. On the contrary: as small and mid caps even outperform large caps in the long term, our fund even benefits from the so-called "size" risk premium with its overweight in small and mid capitalized stocks.

This disciplined approach proved its worth last year. Thanks in part to the underweighting of Nestlé and Roche, the fund closed 2023 more than 2% ahead of the SPI and up 8.21%. The outperformance of 0.66% p.a. compared to the SPI since the fund was launched (Dec. 2010) shows that the strategy also works in the long term. This was achieved with systematically lower volatility.

Recommendation no. 2 - Add small & mid caps

Is the move away from the SPI a little too extreme, and is an active investment solution possibly too expensive? But are you still concerned about the dominance of large caps? One possible solution is to add small & mid caps to the passive implementation in order to reduce the exposure to the index heavyweights. But would you like to do this without the additional volatility associated with this market segment? Then we have the right product for you with OLZ Equity Switzerland Small & Mid Cap Optimized ESG since December 2022. In 2023, it also clearly outperformed the index with a performance of +8.40%. Here too, OLZ risk optimization systematically reduces the investment risk - so much so that the historical average was only just above that of the SPI.

Whether in small Switzerland or big America - whether Nestlé and Roche or Apple and Tesla: it is better to keep certain basic principles of investing in mind. At OLZ, they have always taken center stage.

We are always happy to talk to you.

A lasting relationship with our customers is worth more to us than mere success. Get in touch with us, we look forward to hearing from you. Or contact us directly: